Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Greer
>
Compensation
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 5476611"]WEDNESDAY, July 1, 2015 (HealthDay News) -- The benefit of sublingual immunotherapy (SLIT) over placebo for seasonal grass pollen allergies is small, according to new research published online June 29 in JAMA Internal Medicine.</p><p><br /></p><p>Gabriele Di Lorenzo, M.D., of the department of internal medicine at the University of Palermo in Italy, and colleagues looked at 25 clinical trials that evaluated the effectiveness of grass pollen sublingual tablets in reducing symptoms and the need for other allergy medications. Di Lorenzo told HealthDay that some previous trials overestimated the drugs' benefit because of the way differences between active medicine and placebo were calculated. For the new analysis, the researchers said the real difference was estimated correctly.</p><p><br /></p><p>In the analysis, when SLIT was compared with placebo, symptom scores differed by just 1 point. Study participants could also take allergy medicine, such as antihistamines, and this is what mainly controlled symptoms, Di Lorenzo said. Adverse effects were reported by 61.3 percent of those in the SLIT group and 20.9 percent receiving placebo. Seven patients in the SLIT group reported treatment-related adverse events that required epinephrine.</p><p><br /></p><p>"Findings show a small benefit of the grass pollen sublingual tablets in reducing symptoms and in decreasing the use of symptomatic medication (antihistamines and corticosteroids) in patients with seasonal allergic rhinoconjunctivitis," the authors write. "Considering the low magnitude of the benefit, the convenience and easy administration do not seem to be sufficient reasons for the choice of SLIT."[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 5476611"]WEDNESDAY, July 1, 2015 (HealthDay News) -- The benefit of sublingual immunotherapy (SLIT) over placebo for seasonal grass pollen allergies is small, according to new research published online June 29 in JAMA Internal Medicine. Gabriele Di Lorenzo, M.D., of the department of internal medicine at the University of Palermo in Italy, and colleagues looked at 25 clinical trials that evaluated the effectiveness of grass pollen sublingual tablets in reducing symptoms and the need for other allergy medications. Di Lorenzo told HealthDay that some previous trials overestimated the drugs' benefit because of the way differences between active medicine and placebo were calculated. For the new analysis, the researchers said the real difference was estimated correctly. In the analysis, when SLIT was compared with placebo, symptom scores differed by just 1 point. Study participants could also take allergy medicine, such as antihistamines, and this is what mainly controlled symptoms, Di Lorenzo said. Adverse effects were reported by 61.3 percent of those in the SLIT group and 20.9 percent receiving placebo. Seven patients in the SLIT group reported treatment-related adverse events that required epinephrine. "Findings show a small benefit of the grass pollen sublingual tablets in reducing symptoms and in decreasing the use of symptomatic medication (antihistamines and corticosteroids) in patients with seasonal allergic rhinoconjunctivitis," the authors write. "Considering the low magnitude of the benefit, the convenience and easy administration do not seem to be sufficient reasons for the choice of SLIT."[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Greer
>
Compensation
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Greer
>
Compensation
>